Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome.

V IvashkinYuri M PoluektovE KoganO ShifrinA SheptulinA KovalevaAnastasia KurbatovaG KrasnovE Poluektova

Published in: PloS one (2021)

IBS patients have impaired gut permeability and persisting low-grade inflammation throughout the gastrointestinal tract. Changes in the gut microbiota may support or exacerbate these changes.

Keyphrases

irritable bowel syndrome
low grade
end stage renal disease
high grade
ejection fraction
poor prognosis
newly diagnosed
chronic kidney disease
blood brain barrier
prognostic factors
binding protein
patient reported